Lhasa Limited shared knowledge shared progress

ICH Q3D: Practical implementation and the role of excipient data in a risk based approach

Teasdale A;

Presented as part of the 2016 vICGM series by Dr. Andrew Teasdale, AstraZeneca.

ICH Q3D advocates the use of a risk based approach to the assessment of the risk posed by elemental impurities. A major challenge in adopting such an approach is in balancing the need to generate data through testing against the potential use of existing knowledge. This talk will look to examine this…




Additional Documents

Related Publications

© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.